It looks like the GenesisCare arrangement is already generating income for Noxopharm; income that will grow substantially once GenesisCare expands operations in Europe and the USA
Some excerpts from the announcement:
Dr Gisela Mautner, Chief Medical Officer of Noxopharm, stated: “The heavy lifting has been done for several key aspects of bringing Veyonda® to market. We have shown that Veyonda® is very well tolerated and safe in the patients who have participated in our studies so far. It has also shown to be safe in our compassionate use program which involves even more progressed patients in many cases.
Graham Kelly PhD, Noxopharm CEO, said: “Veyonda® is emerging as a potentially very valuable new therapy. The largest single market sector in oncology is end-stage metastatic cancer, a point at which almost every patient with metastatic cancer eventually finds themselves and is left with few treatment choices beyond palliative care. That very substantial unmet need with limited competition is where we are positioning Veyonda® in the first instance.”
The Company currently is taking steps to ensure that the production line involving raw materials supply, drug synthesis and final product manufacture remains secure ahead of the DARRT-2 study and the growing compassionate use program being conducted in cooperation with GenesisCare.
- Forums
- ASX - By Stock
- Ann: Veyonda Clinical Program Update and Guidance
It looks like the GenesisCare arrangement is already generating...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.0¢ | 11.5¢ | 10.5¢ | $2.964K | 26.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 53298 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 33616 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 53298 | 0.105 |
10 | 263990 | 0.100 |
1 | 100000 | 0.097 |
3 | 152630 | 0.095 |
1 | 53000 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 33616 | 1 |
0.120 | 209728 | 8 |
0.125 | 144133 | 4 |
0.130 | 488878 | 7 |
0.135 | 200000 | 1 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |